Osaic Holdings
CRNX

Osaic Holdings’s Crinetics Pharmaceuticals CRNX Stock Holding History

Osaic Holdings’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.5K Sell
1,858
-63
-3% -$2.34K ﹤0.01% 5231
2026
Q1 		$69.8K Buy
1,921
+165
+9% +$7.37K ﹤0.01% 4949
2025
Q4 		$81.7K Sell
1,756
-765
-30% -$34.1K ﹤0.01% 4871
2025
Q3 		$93.8K Buy
2,521
+43
+2% +$1.38K ﹤0.01% 4845
2025
Q2 		$74.6K Buy
2,478
+1,382
+126% +$42.7K ﹤0.01% 4743
2025
Q1 		$36.8K Sell
1,096
-516
-32% -$19.3K ﹤0.01% 4934
2024
Q4 		$82.4K Sell
1,612
-723
-31% -$40.5K ﹤0.01% 4333
2024
Q3 		$119K Buy
2,335
+35
+2% +$1.8K ﹤0.01% 4092
2024
Q2 		$103K Sell
2,300
-562
-20% -$26K ﹤0.01% 4118
2024
Q1 		$134K Sell
2,862
-13,594
-83% -$532K ﹤0.01% 4027
2023
Q4 		$585K Buy
16,456
+13,008
+377% +$399K ﹤0.01% 3020
2023
Q3 		$103K Buy
3,448
+1,036
+43% +$21.3K ﹤0.01% 4494
2023
Q2 		$43.5K Buy
2,412
+1,912
+382% +$38.1K ﹤0.01% 5027
2023
Q1 		$8.03K Buy
500
+245
+96% +$4.53K ﹤0.01% 6103
2022
Q4 		$4K Hold
255
– – ﹤0.01% 6377
2022
Q3 		$5K Buy
255
+25
+11% +$510 ﹤0.01% 6345
2022
Q2 		$4K Sell
230
-920
-80% -$18.4K ﹤0.01% 6572
2022
Q1 		$26K Sell
1,150
-375
-25% -$7.59K ﹤0.01% 5515
2021
Q4 		$44K Buy
1,525
+75
+5% +$1.85K ﹤0.01% 5243
2021
Q3 		$31K Hold
1,450
– – ﹤0.01% 5456
2021
Q2 		$27K Buy
1,450
+1,000
+222% +$17.6K ﹤0.01% 5464
2021
Q1 		$7K Buy
+450
New +$6.97K ﹤0.01% 6016

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's CRNX Position: Q2 2026 in Review

Osaic Holdings reduced its Crinetics Pharmaceuticals (CRNX) stake by 3.3% in Q2 2026, selling an estimated $2.34K and leaving 1,858 shares worth $69.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5231.

Osaic Holdings first reported a position in CRNX in Q1 2021 and has held it in 22 quarters since. The position peaked at $585K in Q4 2023. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Osaic Holdings held 1,858 shares of Crinetics Pharmaceuticals worth $69.5K as of Q2 2026.
  • Osaic Holdings sold 63 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $2.34K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5231 holding.
  • Osaic Holdings first reported a position in Crinetics Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Osaic Holdings's Crinetics Pharmaceuticals position peaked at $585K in Q4 2023.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.